eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
Melanoma, Melanoma Skin Cancer: Click to Expand ⟱
Melanoma is a rare form of skin cancer. It is more likely to invade nearby tissues and spread to other parts of the body than other types of skin cancer.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Melanoma, |
A375 |
|
|
|
- |
in-vitro, |
Colon, |
HCT15 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
TrxR↓, eff↓, eff↓, other∅,
| - |
in-vivo, |
Melanoma, |
SK-MEL-28 |
|
|
|
- |
in-vivo, |
Melanoma, |
WM35 |
|
|
|
ROS↑, Ca+2↝, Casp3↑, Casp8↑, Casp9↑, CD4+↑, CD8+↑, tumCV↓, eff↓, *toxicity↓,
| - |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Melanoma, |
RPMI-8226 |
|
|
|
AntiCan↑, eff↓, ChemoSen↑, ER Stress↑, tumCV↓, DNAdam↑, GSH∅, HSP70/HSPA5↓, UPR↑, β-catenin/ZEB1↓, ROS↑, HO-2↑, SIRT1↑, GlucoseCon∅, lactateProd∅, chemoP↑,
| - |
in-vitro, |
Lung, |
H1299 |
|
|
|
- |
in-vitro, |
Lung, |
H460 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Melanoma, |
A375 |
|
|
|
- |
in-vitro, |
Lung, |
H2030 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
Glycolysis↓, lactateProd↓, PGK1↓, ALDOA↓, GLUT1↓, ENO1↓, ATP↓, Casp9↑, Casp3↑, cl‑PARP↑, PI3K/Akt↓, HK1↓, HK2↓, ROS↑, Apoptosis↑, eff↓, NADPH↓, PPP↓,
| - |
in-vitro, |
Melanoma, |
U266 |
|
|
|
tumCV↓, Apoptosis↑, BAX↑, Cyt‑c↑, Bcl-2↓, cl‑PARP↑, cl‑Casp3↑, cl‑Casp9↑, ROS↑, eff↓,
| - |
in-vitro, |
Melanoma, |
B16-F10 |
|
|
|
ROS↑, eff↓, tumCV↓, Casp3↑, necrosis↑,
| - |
in-vitro, |
Melanoma, |
U266 |
|
|
|
- |
in-vivo, |
Melanoma, |
NA |
|
|
|
- |
in-vitro, |
Melanoma, |
RPMI-8226 |
|
|
|
Apoptosis↑, TumCCA↑, MMP↓, ROS↑, eff↓, NF-kB↓, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, cl‑PARP1↑, MDA↑, SOD↓, SOD2↓, GCLM↓, GSTA1↓, FTH1↓, GSTs↓, TumVol↓,
AntiCan↑, eff↓,
| - |
in-vitro, |
Melanoma, |
U266 |
|
|
|
TumCD↑, TumCCA↑, Casp3↑, Bcl-2↓, Mcl-1↓, BAX↑, BIM↑, BAD↑, AMPK↑, ACC↑, p‑Akt↓, p‑mTOR↓, ROS↑, eff↓,
| - |
in-vitro, |
Melanoma, |
RPMI-8226 |
|
|
|
TumCG↓, Apoptosis↑, ROS↑, Casp3↑, cl‑PARP↑, SIRT1↓, eff↓,
| - |
in-vitro, |
Melanoma, |
NA |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
TumAuto↓, eff↓, other↓,
| - |
vitro+vivo, |
Melanoma, |
A172 |
|
|
|
TumCG↓, TumCCA↑, Apoptosis↑, P21↑, CycB/CCNB1↓, cycA1/CCNA1↓, CDC2↓, CDC25↑, Bax:Bcl2↑, Casp9↑, ROS↑, JNK↑, ERK↑, eff↓,
| - |
in-vitro, |
Melanoma, |
A375 |
|
|
|
Apoptosis↑, TumAuto↑, TumCP↓, TumCCA↑, P21↑, cycD1/CCND1↓, ER Stress↑, p‑eIF2α↑, CHOP↑, cl‑Casp3↑, p38↑, LC3B-II↑, Beclin-1↑, ROS↑, eff↓,
| - |
in-vitro, |
Melanoma, |
A431 |
|
|
|
ROS↑, Apoptosis↑, P53↑, BAX↑, MDM2↓, Bcl-2↓, Bcl-xL↓, Casp9↑, Casp7↑, Casp3↑, STAT3↓, cycD1/CCND1↓, survivin↓, eff↓,
| - |
in-vitro, |
Melanoma, |
SK-MEL-28 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
Apoptosis↑, JAK2↓, STAT3↓, cycD1/CCND1↓, survivin↓, ROS↑, eff↓,
Showing Research Papers: 1 to 15 of 15
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 15
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
GCLM↓, 1, GSH∅, 1, GSTA1↓, 1, GSTs↓, 1, HK1↓, 1, HO-2↑, 1, MDA↑, 1, ROS↑, 12, SOD↓, 1, SOD2↓, 1, TrxR↓, 1,
Metal & Cofactor Biology ⓘ
FTH1↓, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, CDC2↓, 1, CDC25↑, 1, MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
ACC↑, 1, ALDOA↓, 1, AMPK↑, 1, ENO1↓, 1, GlucoseCon∅, 1, Glycolysis↓, 1, HK2↓, 1, lactateProd↓, 1, lactateProd∅, 1, NADPH↓, 1, PGK1↓, 1, PI3K/Akt↓, 1, PPP↓, 1, SIRT1↓, 1, SIRT1↑, 1,
Cell Death ⓘ
p‑Akt↓, 1, Apoptosis↑, 8, BAD↑, 1, BAX↑, 3, Bax:Bcl2↑, 1, Bcl-2↓, 3, Bcl-xL↓, 1, BIM↑, 1, Casp3↑, 7, cl‑Casp3↑, 2, Casp7↑, 1, Casp8↑, 2, Casp9↑, 5, cl‑Casp9↑, 1, Cyt‑c↑, 2, JNK↑, 1, Mcl-1↓, 1, MDM2↓, 1, necrosis↑, 1, p38↑, 1, survivin↓, 2, TumCD↑, 1,
Transcription & Epigenetics ⓘ
other↓, 1, other∅, 1, tumCV↓, 4,
Protein Folding & ER Stress ⓘ
CHOP↑, 1, p‑eIF2α↑, 1, ER Stress↑, 2, HSP70/HSPA5↓, 1, UPR↑, 1,
Autophagy & Lysosomes ⓘ
Beclin-1↑, 1, LC3B-II↑, 1, TumAuto↓, 1, TumAuto↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 1, cl‑PARP↑, 3, cl‑PARP1↑, 1,
Cell Cycle & Senescence ⓘ
cycA1/CCNA1↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 3, P21↑, 2, TumCCA↑, 4,
Proliferation, Differentiation & Cell State ⓘ
ERK↑, 1, p‑mTOR↓, 1, STAT3↓, 2, TumCG↓, 2,
Migration ⓘ
Ca+2↝, 1, TumCP↓, 1, β-catenin/ZEB1↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 1,
Immune & Inflammatory Signaling ⓘ
CD4+↑, 1, JAK2↓, 1, NF-kB↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, eff↓, 16,
Functional Outcomes ⓘ
AntiCan↑, 2, chemoP↑, 1, TumVol↓, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 91
Pathway results for Effect on Normal Cells:
Functional Outcomes ⓘ
toxicity↓, 1,
Total Targets: 1
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:39 Cells:% prod#:% Target#:961 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page